Initial duration for issuing its decision by PTAB.

No definition available.

Name:	coll_DurationForDecisionIssue
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Extended period for issuing its decision by PTAB.

+ References

No definition available.

+ Details

Name:	coll_ExtendedDurationForDecisionIssue
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of additional cases filed.

+ References

No definition available.

+ Details

Name:	coll_LossContingencyNumberOfAdditionalCasesFiled
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of demand letters received from purported stockholders.

+ References

No definition available.

+ Details

Name:	coll_LossContingencyNumberOfDemandLettersReceivedFromPurportedStockholders
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The reimbursement of investigation cost incurred by the Attorney General.

+ References

No definition available.

+ Details

Name:	coll_LossContingencyReimbursementOfInvestigationCost
Namespace Prefix:	coll_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the stay period before the Federal Drug Administration (FDA) can issue final approval unless the stay is terminated.

+ References

No definition available.

+ Details

Name:	coll_LossContingencyStayPeriodBeforeFinalFederalDrugAdministrationApprovalCanBeIssuedIfPatentInfringementLitigationElected
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of cases still awaiting court sign-off.

+ References

No definition available.

+ Details

Name:	coll_NumberOfCasesStillAwaitingCourtSignOff
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of judge in panel who settled the case.

+ References

No definition available.

+ Details

Name:	coll_NumberOfJudgeInPanel
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of lawsuits designated as Track One case.

+ References

No definition available.

+ Details

Name:	coll_NumberOfLawsuitsDesignatedTrackOneCase
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of patents listed in FDA Orange Book

+ References

No definition available.

+ Details

Name:	coll_NumberOfPatentsListedInFdaOrangeBook
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Statutory period of proceedings.

+ References

No definition available.

+ Details

Name:	coll_StatutoryPeriodOfProceedings
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of claims dismissed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349

+ Details

Name:	us-gaap_LossContingencyClaimsDismissedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of claims settled.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349

+ Details

Name:	us-gaap_LossContingencyClaimsSettledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349

+ Details

Name:	us-gaap_LossContingencyLossInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=coll_PurduePharmaLimitedPartnershipPatentInfringementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_PurduePharmaLimitedPartnershipPatentInfringementDistrictOfDelawareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_PurduePharmaLimitedPartnershipPatentInfringementDistrictOfMassachusettsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_OpioidLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_OpioidLitigationAtPennsylvaniaStateCourtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_OpioidLitigationAtMassachusettsStateCourtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_MultiDistrictLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_OpioidRelatedRequestAndSubpoenasMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=coll_BdsiAcquisitionLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingencies (Details) $ in Thousands																				9 Months Ended	18 Months Ended
Commitments and Contingencies (Details) $ in Thousands	Jul. 22, 2022 lawsuit	May 11, 2022 case	Apr. 19, 2022 case	Apr. 11, 2022 case	Mar. 11, 2022 stockholder	Mar. 09, 2022 stockholder	Mar. 07, 2022 stockholder	Mar. 05, 2022 case	Mar. 04, 2022 stockholder	Mar. 02, 2022 case	Feb. 28, 2022 stockholder case	Feb. 24, 2022 stockholder	Dec. 24, 2021 USD ($) case	Dec. 16, 2021 USD ($)	Sep. 11, 2020	Oct. 02, 2019	Aug. 29, 2019 judge	Mar. 24, 2015 patent	Feb. 11, 2015 patent	Sep. 30, 2022 lawsuit case	Apr. 30, 2017 patent lawsuit
Commitments and Contingencies
Number of lawsuits dismissed			8
Claims settled													27
Xtampza ER Litigation
Commitments and Contingencies
Number of patents listed in FDA Orange Book \| patent																			11
Stay period before FDA can issue a final approval unless it is terminated																			30 months
Number of patents allegedly infringed \| patent																			5		2
Number of lawsuits filed \| lawsuit																					2
PTAB duration for issuing decision																1 year
Statutory period of proceedings															18 months
Xtampza ER Litigation \| Maximum
Commitments and Contingencies
PTAB extended duration for issuing decision																6 months
Xtampza ER Litigation, District of Delaware
Commitments and Contingencies
Stay period before FDA can issue a final approval unless it is terminated																		30 months
Number of patents allegedly infringed \| patent																		3
Xtampza ER Litigation, District of Massachusetts
Commitments and Contingencies
Stay period before FDA can issue a final approval unless it is terminated																		30 months
Number of patents allegedly infringed \| patent																		3
Opioid Litigation
Commitments and Contingencies
Number of lawsuits filed \| lawsuit																				6
Number of lawsuits dismissed			8																	13
Number of lawsuits designated as Track One case \| lawsuit																				0
Litigation settlement, amount awarded to other party \| $													$ 2,750
Claims settled													27
Opioid Litigation \| Maximum
Commitments and Contingencies
Litigation settlement, amount awarded to other party \| $													$ 2,750
Opioid Litigation, Pennsylvania state court
Commitments and Contingencies
Number of cases still awaiting court sign-off				6
Opioid Litigation, Massachusetts state court
Commitments and Contingencies
Number of cases still awaiting court sign-off		13
Number of lawsuits dismissed \| lawsuit	13
Multi-District Litigation (MDL)
Commitments and Contingencies
Number of lawsuits filed																				21
Number of lawsuits dismissed																				3
Opioid-Related Request and Subpoenas
Commitments and Contingencies
Agreed to pay attorney general \| $														$ 185
Reimbursement of investigation cost of the attorney general \| $														$ 65
BDSI Acquisition Litigation
Commitments and Contingencies
Number of additional cases filed								2		2	2
Number of demand letters received from purported stockholders \| stockholder					4	4	3		4		3	3
Number of judge in panel \| judge																	3